Cartesian Therapeutics, Inc. (RNAC)
8.17
-0.17
(-2.04%)
USD |
NASDAQ |
May 07, 16:00
8.17
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Research and Development Expense (Annual) : 58.03M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Insmed, Inc. | 771.09M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Precision BioSciences, Inc. | 52.87M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |